| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/05/2004 | US20040151719 Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 08/05/2004 | US20040151718 Cell surface molecule mediating cell adhesion and signal transmission |
| 08/05/2004 | US20040151715 Catalytic domain of ADAM33 and methods of use thereof |
| 08/05/2004 | US20040151713 Cell cycle regulatory factor |
| 08/05/2004 | US20040151712 Modulation of inflammation related to columnar epithelia |
| 08/05/2004 | US20040151707 Vascular cells genetically altered to over-express angiogenic proliferation and maturation factors; treatment of atherosclerosis using same |
| 08/05/2004 | US20040151695 Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same |
| 08/05/2004 | US20040151669 Lymph cells detected by monoclonal antibodies; diagnosis of autoimmune disease, antiallergens |
| 08/05/2004 | DE10303974A1 Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung Amyloid-β (1-42) oligomers, processes for their preparation and their use |
| 08/05/2004 | CA2514184A1 Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same |
| 08/05/2004 | CA2513904A1 Protein domain related to deafness, osteoarthritis and abnormal cell proliferation |
| 08/05/2004 | CA2513711A1 Process for the preparation of hypoallergenic mosaic antigens |
| 08/05/2004 | CA2513584A1 The use of yop proteins or rho gtpase inhibitors as caspase-1 inhibitors |
| 08/05/2004 | CA2513460A1 Human saa3 nucleic acid molecule, protein, and methods of use for same |
| 08/05/2004 | CA2513320A1 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 08/05/2004 | CA2513308A1 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 08/05/2004 | CA2513044A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 08/05/2004 | CA2512917A1 Methods for increasing neisseria protein expression |
| 08/05/2004 | CA2511570A1 Composition and method for preventing or treating a virus infection |
| 08/05/2004 | CA2506855A1 Mntf peptides and compositions and methods of use |
| 08/04/2004 | EP1443446A1 Method of presuming domain linker region of protein |
| 08/04/2004 | EP1443112A2 Macrophage activating factors derived from cloned vitamin D binding protein |
| 08/04/2004 | EP1443111A1 Desmin gene having novel point mutation causative of dilated cardiomyopathy |
| 08/04/2004 | EP1443109A1 Primers and method of detecting bacteria |
| 08/04/2004 | EP1443056A1 IL-6 receptor.IL-6 direct fusion protein |
| 08/04/2004 | EP1443055A2 Interleukins-21 and 22 |
| 08/04/2004 | EP1443054A1 Anitmicrobial proteins, genes encoding the proteins and mehtod of using the same |
| 08/04/2004 | EP1443053A1 Analgesic antitumor peptide from scorpion and method of producing it |
| 08/04/2004 | EP1442747A1 Superoxide dismutase and mimetics thereof |
| 08/04/2004 | EP1442301A1 Means and methods for the detection of immunoglobulin capable of binding to mycobacterium antigen |
| 08/04/2004 | EP1442297A2 Methods for screening osteogenic compounds |
| 08/04/2004 | EP1442295A2 Periostin-based diagnostic assays |
| 08/04/2004 | EP1442134A2 Method for producing and identifying soluble protein domains |
| 08/04/2004 | EP1442127A2 Stress tolerant plants |
| 08/04/2004 | EP1442124A1 Polypeptide antigen forming a mimetic structure of the gp41 intermediate state |
| 08/04/2004 | EP1442123A2 Polynucleotides and polypeptides involved in clavulinic acid biosynthesis and use thereof |
| 08/04/2004 | EP1442121A2 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents |
| 08/04/2004 | EP1442117A1 Gastrointestinal chemosensory receptors |
| 08/04/2004 | EP1442114A2 Novel bacterial poultry disease |
| 08/04/2004 | EP1442062A2 Methods for the treatment of carcinoma |
| 08/04/2004 | EP1442060A2 A novel g protein-coupled receptor, gave 10 |
| 08/04/2004 | EP1442059A2 Analogs of human growth hormone-releasing hormone, their preparation and use |
| 08/04/2004 | EP1442058A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/04/2004 | EP1442057A1 Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy |
| 08/04/2004 | EP1442056A1 Diagnosis and treatment of infectious diseases through indel-differentiated proteins |
| 08/04/2004 | EP1442055A1 Aequorin as a growth marker in yeast |
| 08/04/2004 | EP1442054A1 Aequorin as a reporter gene in yeast |
| 08/04/2004 | EP1442053A2 New protein of the defensin family from oil palm |
| 08/04/2004 | EP1442052A1 High level constitutive production of anthrax protective antigen |
| 08/04/2004 | EP1442051A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 08/04/2004 | EP1442047A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/04/2004 | EP1442046A2 Mammalian c-type lectins |
| 08/04/2004 | EP1442022A2 Polyamide modulators of cox2 transcription |
| 08/04/2004 | EP1441773A1 Pacap compositions and methods for tumor imaging and therapy |
| 08/04/2004 | EP1441764A2 Antigen arrays comprising rankl for treatment of bone disease |
| 08/04/2004 | EP1441762A1 Rsv gene expression vaccine |
| 08/04/2004 | EP1441761A2 Methods of preventing and treating flavivirus infection in animals |
| 08/04/2004 | EP1441756A1 Psp-94: use for treatment of hypercalcemia and bone metastasis |
| 08/04/2004 | EP1441753A2 Cell cycle progression proteins |
| 08/04/2004 | EP1441752A1 Endophilin homologous proteins involved in the regulation of energy homeostasis |
| 08/04/2004 | EP1441750A2 Linear and cyclic melanocortin receptor-specific peptides |
| 08/04/2004 | EP1441742A2 Axon repair |
| 08/04/2004 | EP1261628A4 Novel molecules of the card-related protein family and uses thereof |
| 08/04/2004 | EP1259543A4 Purification of vascular endothelial growth factor-b |
| 08/04/2004 | EP1171465B1 Analogs of gastric inhibitory peptide and their use for treatment of diabetes |
| 08/04/2004 | EP1171151A4 Thrombospondin-2 and uses thereof |
| 08/04/2004 | EP1117813B1 Geminivirus resistant transgenic plants |
| 08/04/2004 | EP1068529A4 Methods and compounds for modulating nuclear receptor coactivator binding |
| 08/04/2004 | EP1017799A4 Mutant mhc class i molecules |
| 08/04/2004 | EP0975665B1 Active substance and composition inhibiting tumorous proliferation in ectoderm derived tissues |
| 08/04/2004 | EP0832291A4 Enzyme linked oligonucleotide assays (elonas) |
| 08/04/2004 | EP0790835B1 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| 08/04/2004 | EP0764171B1 Ligands for induction of antigen specific apoptosis in t cells |
| 08/04/2004 | EP0740708B1 Design of drugs involving receptor-ligand-dna interactions |
| 08/04/2004 | EP0725829B1 Methods and compositions for high protein production from recombinant dna |
| 08/04/2004 | EP0637963B1 Cd28 pathway immunoregulation |
| 08/04/2004 | EP0480949B2 Production of viral vaccine |
| 08/04/2004 | CN1518598A Serpin in Bifidobacteria |
| 08/04/2004 | CN1518597A Novel fibroblast growth factors |
| 08/04/2004 | CN1518596A Transgenic non-hyman animals for pharmacological and toxicological studies |
| 08/04/2004 | CN1518592A Male contraceptives |
| 08/04/2004 | CN1518558A Peptides and/or proteins and use thereof for production of therapeutic and/or prophylactic medicament |
| 08/04/2004 | CN1518457A Methods of inducing cytotoxic immune response and recombinant simian ademovirus compositions useful therein |
| 08/04/2004 | CN1517364A Deletion type human interleukin 11 microvariant |
| 08/04/2004 | CN1517363A Novel human keratinocyte growth factor mutant |
| 08/04/2004 | CN1517362A New Polypeptide-human ribosome protein s9 containing ATP/GTP conjugated structure domain and polynucleotide coding said polypetide |
| 08/04/2004 | CN1160472C Human tumor concerned genes in sub-zone 3 of zone 3 of region 1 of chromosome 17 and inspecting reagent box |
| 08/04/2004 | CN1160470C Method for studying protein interactions i(invivo) |
| 08/04/2004 | CN1160469C Identification of genes |
| 08/04/2004 | CN1160465C Funguns wherein areA, pepC and/or pepE genes have been inactivated |
| 08/04/2004 | CN1160464C Process for preparing human muscle hemoglobin by gene recombination |
| 08/04/2004 | CN1160462C Use of gram-positive bacteria to express recombinant proteins |
| 08/04/2004 | CN1160460C Gene sequency of specific dihydro-flavono14-reducing enayme as code substrate and its use thereof |
| 08/04/2004 | CN1160457C Recombinant mistletoe lectin (rML) |
| 08/04/2004 | CN1160371C NOTCH protein and their ligands |
| 08/04/2004 | CN1160370C Novel human cell cysle control related protein and sequence encoding the same |
| 08/04/2004 | CN1160369C Preparation of anti cytoplasmic thymidine kinase-IgY antibody and tumor diagnosis composition |
| 08/04/2004 | CN1160119C Functions for Tob gene in central nervous system of mammol and its application |
| 08/03/2004 | US6770800 Modulating chromosomal duplication in plants; obtain cells, transform with expression vector containing replicase, monitor replication in cells |
| 08/03/2004 | US6770798 Transformed plants conferring on them resistance to diseases of fungal origin |